These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 26222538

  • 1. An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
    Chit A, Roiz J, Aballea S.
    PLoS One; 2015; 10(7):e0133606. PubMed ID: 26222538
    [Abstract] [Full Text] [Related]

  • 2. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
    Chit A, Roiz J, Briquet B, Greenberg DP.
    Vaccine; 2015 Jan 29; 33(5):734-41. PubMed ID: 25444791
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA.
    Hum Vaccin Immunother; 2014 Jan 29; 10(5):1171-80. PubMed ID: 24609063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB, Nolan T, Borja-Tabora CF, Santos J, Montalban MC, de Looze FJ, Eizenberg P, Hall S, Dupuy M, Hutagalung Y, Pépin S, Saville M.
    Vaccine; 2015 May 15; 33(21):2485-92. PubMed ID: 25843270
    [Abstract] [Full Text] [Related]

  • 9. Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
    Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M.
    PLoS Med; 2010 Apr 06; 7(4):e1000256. PubMed ID: 20386727
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
    Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, Spencer S, Fry AM, Flannery B.
    Clin Infect Dis; 2021 Apr 08; 72(7):1147-1157. PubMed ID: 32006430
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Treanor JT, Albano FR, Sawlwin DC, Graves Jones A, Airey J, Formica N, Matassa V, Leong J.
    Vaccine; 2017 Apr 04; 35(15):1856-1864. PubMed ID: 28302411
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.
    BMC Infect Dis; 2015 Oct 27; 15():465. PubMed ID: 26503131
    [Abstract] [Full Text] [Related]

  • 13. Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review.
    Warmath CR, Ortega-Sanchez IR, Duca LM, Porter RM, Usher MG, Bresee JS, Lafond KE, Davis WW.
    Value Health; 2023 May 27; 26(5):768-779. PubMed ID: 36436790
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, Tsang PH.
    Vaccine; 2015 Feb 25; 33(9):1151-9. PubMed ID: 25613721
    [Abstract] [Full Text] [Related]

  • 15. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
    Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA.
    Clin Infect Dis; 2021 Sep 07; 73(5):816-823. PubMed ID: 33605977
    [Abstract] [Full Text] [Related]

  • 16. Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand.
    Kittikraisak W, Chittaganpitch M, Gregory CJ, Laosiritaworn Y, Thantithaveewat T, Dawood FS, Lindblade KA.
    Influenza Other Respir Viruses; 2016 May 07; 10(3):211-9. PubMed ID: 26588892
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G, Gregg M, Poulsen Nautrup B.
    J Med Econ; 2015 May 07; 18(9):746-61. PubMed ID: 25903831
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M.
    Lancet Infect Dis; 2015 Dec 07; 15(12):1459-66. PubMed ID: 26362172
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.
    Pepin S, Szymanski H, Rochín Kobashi IA, Villagomez Martinez S, González Zamora JF, Brzostek J, Huang LM, Chiu CH, Chen PY, Ahonen A, Forstén A, Seppä I, Quiroz RF, Korhonen T, Rivas E, Monfredo C, Hutagalung Y, Menezes J, Vesikari T.
    Hum Vaccin Immunother; 2016 Dec 07; 12(12):3072-3078. PubMed ID: 27565435
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
    Mennini FS, Bini C, Marcellusi A, Rinaldi A, Franco E.
    Hum Vaccin Immunother; 2018 Dec 07; 14(8):1867-1873. PubMed ID: 29708843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.